Latest Breast Cancer Research and Treatment Stories
Regular mammography screening can help narrow the breast cancer gap between black and white women.
A new study analyses the influence that certain birth and infancy characteristics have on mammographic density – an important indicator of breast cancer risk.
Researchers at Linköping University are now launching a plan to effectively treat psoriasis.
As a woman ages, her chances of being diagnosed with a lower-risk breast tumor increase.
Researchers exploring why some women who take a common breast cancer drug develop serious joint pain have eliminated two possible causes: inflammatory arthritis and autoimmune disease.
Researchers from Virginia Commonwealth University Massey Cancer Center have discovered a new biomarker related to the body's immune system that can predict a breast cancer patients' risk of cancer recurrence.
ACE inhibitors, commonly used to control high blood pressure and heart failure in women, may be associated with an increased risk of recurrence in women who have had breast cancer, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center.
EMERYVILLE, Calif., Dec. 8, 2010 /PRNewswire/ -- Bionovo, Inc. (Nasdaq: BNVI) today announced the publication of a study demonstrating that ERb causes cancer cell growth arrest by inactivating critical genes and enzymes responsible for cell growth.
U.S. Senator Robert Patrick Casey receives Pink Ribbon Award EPHRATA, Pa., Oct. 5 /PRNewswire-USNewswire/ -- U.S. Senator Robert P. Casey, Jr., a breast cancer advocate for the women of Pennsylvania, will receive the Pink Ribbon Award from the PA Breast Cancer Coalition (PBCC).
Researchers at the Indiana University Melvin and Bren Simon Cancer Center have published the first report using imaging to show that changes in brain tissue can occur in breast cancer patients undergoing chemotherapy.
Breast Cancer Research and Treatment is a peer-reviewed scientific journal published by Springer Verlag. It focuses on the treatment of and investigations in breast cancer. The journal is targeted towards a wide audience of clinical researchers, epidemiologists, immunologists, and cell biologists whom are interested in breast cancer. Articles in this journal include: original research, invited reviews, discussions on controversial issues, book reviews, meeting reports, letters to the editors,...
- totally perplexed and mixed up.